Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 13,880 | 6,296 | 8,522 | 86,276 | 10,013 |
| Operating Income | -13,880 | -6,296 | -8,522 | -86,276 | -10,013 |
| Other Income | 10,482 | -3,079 | 634 | 290 | -72 |
| Pre-tax Income | -3,398 | -9,375 | -7,888 | -85,986 | -10,085 |
| Net Income Continuous | -3,398 | -9,375 | -7,952 | -85,986 | -10,085 |
| Net Income | $-3,398 | $-9,375 | $-7,952 | $-85,986 | $-10,085 |
| EPS Basic Total Ops | -434.78 | -1,311.84 | -1,641.68 | -12,754.87 | -1,799.10 |
| EPS Basic Continuous Ops | -433.20 | -1,310.66 | -1,686.10 | -12,753.71 | -1,781.00 |
| EPS Diluted Total Ops | -434.78 | -1,311.84 | -1,641.68 | -12,754.87 | -1,799.10 |
| EPS Diluted Continuous Ops | -433.20 | -1,310.66 | -1,686.10 | -12,753.71 | -1,781.00 |
| EBITDA(a) | $-13,728 | $-6,158 | $-8,399 | $-86,152 | $-9,896 |